abstract |
this application relates to innovative pharmaceutical dosage forms that comprise potent and selective inhibitors of task-1 and / or task-3 channels and their use for the treatment and / or prevention of respiratory disorders, including respiratory disorders related to sleep, such as obstructive and central sleep apneas and snoring. |